scholarly journals SOME STUDIES ON PASTEURELLA MULTOCIDA AS A CAUSATIVE AGENT OF MASTITIS IN DAIRY COWS AND EWES

2016 ◽  
Vol 62 (150) ◽  
pp. 143-156
2018 ◽  
Vol 7 (18) ◽  
Author(s):  
Serajus Salaheen ◽  
Seon Woo Kim ◽  
Jeffrey S. Karns ◽  
Bradd J. Haley ◽  
Jo Ann S. Van Kessel

Cattle are primary reservoirs of Escherichia coli O157:H7, a causative agent of severe human infections. To facilitate analyses of the communities in which this pathogen is found, we sequenced the fecal metagenomes of 10 dairy cows shedding E. coli O157:H7 and added them to the public domain.


RSC Advances ◽  
2020 ◽  
Vol 10 (51) ◽  
pp. 30917-30933
Author(s):  
Abdul Tawab ◽  
Noor Akbar ◽  
Mujtaba Hasssan ◽  
Fazale Habib ◽  
Aamir Ali ◽  
...  

LC/MS-based variant profiling of lipid A component of endotoxic lipopolysaccharides of Pasteurella multocida type B:2, a causative agent of haemorrhagic septicaemia in water buffalo and cattle.


2003 ◽  
Vol 71 (9) ◽  
pp. 5440-5446 ◽  
Author(s):  
Marina Harper ◽  
John D. Boyce ◽  
Ian W. Wilkie ◽  
Ben Adler

ABSTRACT Pasteurella multocida is the causative agent of fowl cholera in birds. Signature-tagged mutagenesis (STM) was used to identify potential virulence factors in a mouse septicemia disease model and a chicken fowl cholera model. A library of P. multocida mutants was constructed with a modified Tn916 and screened for attenuation in both animal models. Mutants identified by the STM screening were confirmed as attenuated by competitive growth assays in both chickens and mice. Of the 15 mutants identified in the chicken model, only 5 were also attenuated in mice, showing for the first time the presence of host-specific virulence factors and indicating the importance of screening for attenuation in the natural host.


2004 ◽  
Vol 72 (6) ◽  
pp. 3436-3443 ◽  
Author(s):  
Marina Harper ◽  
Andrew D. Cox ◽  
Frank St. Michael ◽  
Ian W. Wilkie ◽  
John D. Boyce ◽  
...  

ABSTRACT Pasteurella multocida is the causative agent of fowl cholera in birds. In a previous study using signature-tagged mutagenesis, we identified a mutant, AL251, which was attenuated for virulence in mice and in the natural chicken host. Sequence analysis indicated that AL251 had an insertional inactivation of the gene waaQPM , encoding a putative heptosyl transferase, required for the addition of heptose to lipopolysaccharide (LPS) (M. Harper, J. D. Boyce, I. W. Wilkie, and B. Adler, Infect. Immun. 71:5440-5446, 2003). In the present study, using mass spectrometry and nuclear magnetic resonance, we have confirmed the identity of the enzyme encoded by waaQPM as a heptosyl transferase III and demonstrated that the predominant LPS glycoforms isolated from this mutant are severely truncated. Complementation experiments demonstrated that providing a functional waaQPM gene in trans can restore both the LPS to its full length and growth in mice to wild-type levels. Furthermore, we have shown that mutant AL251 is unable to cause fowl cholera in chickens and that the attenuation observed is not due to increased serum sensitivity.


2005 ◽  
Vol 29 (1) ◽  
pp. 11-21
Author(s):  
Hatem M . Mhanam

It was possible to obtain 17 isolates of Pasteurella multocida frominfected laying chickens with fowl cholera. Three isolates were from the chronicphases of the naturally infected chickens and other fourteen were from the acutephases. The identification of these isolates was considered. Fifteen isolatesbelong to the sub species multocida and two isolates to gallicida, ten isolatesbelong to the SE-190 isolate and one to SE-077, while six isolates were notidentified. Twelve of the isolates have a capsule. The LD50s of these isolateswere varied. The results of sensitivity to antibacterial drugs revieled that allisolates were sensitive to Penicillin and resistance to Lincomycin with variousdegrees of sensitivity to other antibacterial drugs.


2017 ◽  
Vol 71 (2) ◽  
pp. 117-122
Author(s):  
Dubravka Milanov ◽  
Nevenka Aleksic ◽  
Dalibor Todorovic ◽  
Dejan Bugarski

Pasteurella (P.) multocida is a heterogeneous species of Gram-negative bacteria which are common commensals of the upper respiratory system of various mammal and bird species, but are also opportunistic contagious zoonotic pathogens which cause a wide spectre of infections in domestic animals and humans. P. multocida is a rare cause of mastitis in dairy cows. The source of infection mainly remains unknown, mastitis usually is acute, and the therapy by intramammary administration of antibiotics does not lead to satisfactory results. Lethality is possible due to presence of endotoxins in blood. Literature data on P. multocida mastitis in dairy cows is particularly scarce, which is why such a case is described in the current work, with past medical history, clinical findings, laboratory diagnostics and therapeutic approach.


1982 ◽  
Vol 28 (9) ◽  
pp. 1078-1080 ◽  
Author(s):  
J. L. Bhasin

Outbreaks of fowl cholera continue to plague the Canadian poultry industry despite widespread immunization against the causative agent, Pasteurella multocida. Fowl cholera bacterins currently employed by domestic poultry growers contain three serological types, namely, serotypes 1, 3, and 4. In this study a total of 84 strains of P. multocida were isolated in Canada from outbreaks of fowl cholera in turkeys and chickens. Serotyping was accomplished using the gel diffusion precipitin test. Based on the gel diffusion precipitation patterns, 27 serotypes containing one to six antigenic determinants were recognized. The most prevalent serotype both in turkeys and chickens appeared to be type 3. Significantly, greater than 20% of P. multocida isolates failed to react with antisera raised against serotypes 1, 3, and 4.


2020 ◽  
Vol 7 (4) ◽  
pp. 163
Author(s):  
Tawatchai Singhla ◽  
Pallop Tankaew ◽  
Nattawooti Sthitmatee

The objective of this study was to estimate sensitivity (Se) and specificity (Sp) of a novel enzyme-linked immunosorbent assay (ELISA) test (using a coating antigen from Pasteurella multocida M-1404 via heat extraction) and an indirect hemagglutination (IHA) test for detection of Hemorrhagic septicemia (HS) in dairy cows, under Thai conditions, using a Bayesian approach. Dairy cow sera with a total of 1236 samples from 44 farms were tested with the two tests to detect immune responses against the HS. Percentages of positive samples for the ELISA and IHA tests were 73% (901/1236) and 70% (860/1236), respectively. Estimated sensitivity and estimated specificity of the ELISA test were 90.5% (95% posterior probability interval (PPI) = 83.2–95.4%) and 70.8% (95% PPI = 60.8–79.8%), respectively. Additionally, estimates for the Se and Sp values of the IHA test were 77.0% (95% PPI = 70.8–84.1%) and 51.1% (PPI = 36.8–66.3%), respectively. The estimated prevalence of the disease was 71.7% (95% PPI = 62.7–82.6%). These results demonstrate that the ELISA test can be a useful tool for the detection of the presence of an antibody against the HS in dairy cows. Notably, the cows in this area indicated a high percentage of exposure to Pasteurella multocida.


2020 ◽  
Vol 2 ◽  
pp. 99-103
Author(s):  
D.V. Yurin ◽  
◽  
V. V. Nevzorova ◽  
A.A. Balbutskaya ◽  
S.S. Belimova ◽  
...  

Continuouse use of enrofloxacin contributes to emergence of enrofloxacin-resistant mi-crobial resistance, isolated and reported late-ly. In this study we deal with the spread of resistance of enrofloxacin among pathogenic organisms, infecting animals. The suscepti-bility to enrofloxacin was studied in standard disc diffusion assay. We studied 437 bacteri-al isolates in total. Salmonella dublin and Sal-monella typhimurium showed the highest suscepti-bility to enrofloxacin (100%); Salmonella enter-itidis and Salmonella choleraesuis proved a bit less susceptibility (95% and 94,7%). 5% of S. enter-itidis isolates and 5.3% of S. choleraesuis isolates had intermediate susceptibility. We did not register any resistance of isolates of Salmonella, Pasteurella and Morganella (Pasteurella multocida, Morganel-la morganii). 83.9% of Escherichiacoli strains proved susceptibility to enrofloxacin, the zone of retardation in 6.4% of the isolates was in corre-spondence with intermediate susceptibility, 9.7% of the isolates proved to be resistant. 90,9% of Pseudomonas aeruginosa isolates in our study was susceptible to enrofloxacin, 9.1% of them had intermediate susceptibility. The isolates of Strepto-coccus spp. and Staphylococcus pseudintermedius re-vealed high susceptibility to enrofloxacin, also as Listeria monocytogenes (causative agent of listeriosis)and Erysipe-lothrix rhusiopathiae (causative agent of swine erysipelas). 87.5% of the coagulase negative staphylococci proved susceptible to enrofloxacin; 6.25% of the isolates were resistant or had intermediate susceptibility. The shares of susceptible isolates of Staphylococcus hyicus, Staphylococ-cus aureus and Streptococcus uberis were respec-tively 65.1%, 75%, 75%. The shares of isolates with intermediate susceptibility of the same spp. were respectively 9.3%, 15%, 25%. The shares of resistant isolates of Staphylococci were respective-ly 25.6% and 10%. We found no strains of Str. uberis with resistance to enrofloxacin. As for Enterococci, 52.4% of the isolates were enrofloxacin-susceptible, 11,9% and 37,7% of them were re-spectively enrofloxacin-resistant or had intermedi-ate susceptibility. Presently most Gram-negative pathogenic bacteria have no resistance to enroflox-acin. Notwithstanding that enrofloxacin is signifi-cantly less effective against such pathogenic organ-isms as Staphylococci and Streptococci.


Sign in / Sign up

Export Citation Format

Share Document